FDA: Suicide risk higher among children using antidepressants

In an assessment greatly at odds with the psychiatric profession, the FDA said for the first time Monday that clinical trials of Prozac, Paxil and Zoloft show more suicide risk to children taking those drugs than those taking dummy pills. Families pleaded for more urgent FDA action before an expert advisory panel hearing, but the agency has asked for a second analysis of the data by summer before it will decide on any regulatory action.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA